EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Anti-Inflammatory Interventions for Autism Spectrum Disorder

Haily Holston, Avani Karvat, Simran Lallian, PingJu Wu

Berkeley Pharma Tech Journal of Medicine · 2024

DOI: 10.52243/bptjm.v4i1.56 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Berkeley Pharma Tech Journal of Medicine, 2024. Verfasst von Haily Holston und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

One of the defining factors of Autism Spectrum Disorder (ASD) is neuroinflammation, which may be targeted to find effective therapies in managing ASD symptoms. Some promising treatments include mesenchymal STEM cell (MSCs) therapy, cxytocin (OT), sulforaphane (SFN), and resveratrol (RSV). MSCs are located in many parts of the body that can reduce secondary neurodegeneration and neuroinflammation while promoting neurogenesis and angiogenesis. OT is a hormone that moderates social and emotional communication, bonding, and social learning, while also having profound antiinflammatory effects. SFN is a naturally occurring compound in cruciferous vegetables, such as broccoli and sprouts, and activates a transcription factor which regulates anti-inflammatory and antioxidant genes. RSV is found in plants, such as grapes and berries, and helps stabilize the central and peripheral immune response and oxidative stress markers, subsequently reducing neuroinflammation. All of these treatments have shown promising potential, but it is abundantly clear that further research is needed in addition to combined therapies. Since ASD is a spectrum, not every case can be treated the exact same way. By targeting neuroinflammation, we can address the root cause of ASD rather than the symptoms.

Zitieren

APA

Holston, H., Karvat, A., Lallian, S., & Wu, P. (2024). Anti-Inflammatory Interventions for Autism Spectrum Disorder. Berkeley Pharma Tech Journal of Medicine. https://doi.org/10.52243/bptjm.v4i1.56

Vancouver

Holston H, Karvat A, Lallian S, Wu P. Anti-Inflammatory Interventions for Autism Spectrum Disorder. Berkeley Pharma Tech Journal of Medicine. 2024. doi:10.52243/bptjm.v4i1.56

BibTeX
@article{Holston2024,
  author = {Holston, Haily and Karvat, Avani and Lallian, Simran and Wu, PingJu},
  title = {Anti-Inflammatory Interventions for Autism Spectrum Disorder},
  journal = {Berkeley Pharma Tech Journal of Medicine},
  year = {2024},
  doi = {10.52243/bptjm.v4i1.56}
}
Kostenlos starten →